Melasma and Endometriosis: Is There a Hormonal Connection?

Watch the original video on TikTok

Full transcript of the original video, lightly edited for readability.

I wanna show you something that may completely change how you look at melasma. Because melasma is usually treated like a cosmetic skin issue. Dark patches, sun exposure, pregnancy, birth control hormones. And yes, that's part of it. But what if melasma is not just a skin problem? What if, in some women, melasma is the skin showing you the same deeper biological pattern that is happening inside the pelvis with endometriosis? Because when you actually look at the genetic data, the hormone receptor behaviour and the pigment patterns connected to endometriosis, this starts looking a lot less like coincidence and a lot more like a systemic fingerprint.

Now, let's start with the genetics. There are shared regions of the genome that appear connected to both pigment biology and endometriosis. And one of the biggest areas that stands out is the 9 p 21.3 region, where we find C D K and 2A and C D K and 2B. These genes matter because they are cell cycle break systems. They help regulate whether a cell should slow down, stop dividing, repair damage, enter senescence or be removed. So when these pathways are altered, weakened or contextually dysregulated, you can get cells that behave differently depending on where they are.

In the skin, that may show up as pigment cells becoming overactive. In the pelvis, that may show up as endometrial like cells surviving, implanting, remodeling tissue and refusing to die when they should. Same genetic neighborhood, different tissue, different outcome. That is the key. Then we look ATP 10. P 10 is another major regulator. It acts like a break on the PI3K AKT. Pathway, which controls growth, survival, metabolism, and resistance to cell death. When P 10 signaling is disrupted, cells become harder to shut down.

In melanocytes, that can support abnormal pigment cell activity. In endometriosis, that can support lesion survival, invasion, and persistence. Again, same underlying biological logic, different tissue expression. And then we have the estrogen receptor genes, especially ESR1 and ESR2. ESR1 codes for estrogen receptor alpha. ESR2 codes for estrogen receptor beta. And this is where the connection gets extremely important, because melasma affected skin has been shown to have increased estrogen receptor expression in the affected areas. Meaning the darkened patches are not just passively reacting to the sun.

They are hormonally sensitive, they are estrogen responsive, they are biologically primed. Now, compare that to endometriosis. Endometriosis is famous for estrogen receptor beta over expression. Not a tiny increase, a major receptor imbalance. Endometriotic tissue tends to become dominated by ER-beta signaling, which helps drive inflammation, survival, progesterone resistance, and lesion persistence. So now we're seeing a pattern. Melasma lesions increased estrogen receptor sensitivity in skin. Endometriosis lesions increased estrogen receptor beta activity in pelvic tissue. Different organs, same hormonal language. And this matters because estrogen specifically does not act vaguely.

It has very specific mechanisms. In Melanocytes estrogen acts through two main pathways. The first is the genomic pathway. Estrogen binds to ER-alpha or ER-beta. That receptor complex then moves into the nucleus. Once inside the nucleus, it binds to estrogen response elements, or EREs, in the promoter regions of pigment related genes. That increases transcription of genes like Tyr, which codes for tyrosinase and MITF, which is basically the master regulator of melanogenesis. So in simple terms, estrogen tells the pigment machinery to turn on.

More MITF, more tyrosinase, more melanin, more darkening. That's the slow genomic pathway. But there's also the fast pathway, the non genomic pathway. Estrogen combined to G protein coupled estrogen receptor, or GPER. At the cell membrane. That triggers rapid increases in intracellular Calcium and cAMP. Those messengers activate protein kinases that stimulate MITF activity almost immediately. In short, this is the express lane on why skin darkens so rapidly in some cases. Ever wonder why your melasma flares up at the same time your pelvic pain zaps down your leg?

It's because they are using the exact same express lane. The G P R. Receptor on your nerves is causing the pain, while the G P R. Receptor on your skin is triggering the pigment. It's the same hormonal hijack, just in two different places. So even before the cell changes gene expression, long term, estrogen can rapidly push pigment production through signalling cascades. That is why hormonal melasma Can feel like it appears out of nowhere. Because in a hormonally primed melanocyte, estrogen is not just a background hormone, it is a command signal.

Now, here's where it gets even more interesting. There is emerging evidence that melasma affected areas may have localized hormone activity. Meaning the skin itself may not just be responding to hormones from the bloodstream. It may be participating in its own local hormone environment. That sounds very familiar, because this is exactly what we see in endometriosis. Endometriotic lesions are not just responding to systemic estrogen. They can create a local estrogen dominant microenvironment through aromatase activity. This is why a woman can be told, your estrogen looks normal, while her lesions are still behaving like they are drowning in estrogen.

Because the problem may not only be in the blood, it may be in the tissue. The tissue can become its own hormone factory. Then melasma becomes much more than a surface level pigmentation issue. It becomes a visible sign of tissue specific hormonal dysregulation. Now let's bring in the pigment traits, because this is another major clue. Women with lighter skin traits, women who burn more easily, women who do not tan well, women with higher freckling patterns, and women with certain pigmentary phenotypes.

Have been associated with a higher likelihood of endometriosis. That is not random, because pigment biology and endometriosis risk appear to share genetic overlap. Genes involved in pigmentation, U V. Response, melanocyte behavior, DNA. Repair, And cell survival may also intersect with the biology that allows endometriotic cells to persist. So when we see a woman who cannot tan well, who burns easily, who has hormonal pigmentation issues, who develops melasma, and also has pelvic pain, cycle dysfunction, infertility, bowel symptoms, bladder symptoms, or leg pain, I'm not looking at two separate stories.

I'm looking at one biological pattern expressing itself through different tissues. Now, yes, inflammation still matters. NF-kappa B. Matters, COX-2 matters. PGE2 matters. IL-6, IL-17, oxidative stress, R O S, immune dysregulation, all of that matters. But those are not the whole story. Those are the amplifiers. The deeper question is, why are these tissues primed to respond this way in the first place? And that takes us back to genetics, epigenetics, receptor density, and tissue specific expression. This is the part most people miss.

They look at melasma and say, that's skin. They look at endometriosis and say, that's pelvis. In melanocytes, it may show up as pigmentation. In endometrial like cells, it may show up as lesion survival. In immune cells, it may show up as chronic inflammation. In thyroid tissue, it may show up as endocrine instability. In the gut, it may show up as altered estrogen metabolism. Same body, same woman, different tissue context, different symptom. And this is why I keep saying endometriosis is not just a pelvic disease.

It is a systemic expression of Molecular dysregulation and melasma may be one of the visible clues. Not always, not in every woman, but in enough women that we need to stop dismissing it as vanity. Because your skin may be showing what your pelvis has been screaming. And this further supports my theory. These mutations and epigenetic patterns are not isolated to one organ. They may be found throughout the body. But the way they manifest depends on the tissue they are found in.

In the skin, the mutation speaks pigmentation. In the pelvis, it speaks endometriosis. In the immune system, it speaks inflammation. In the endocrine system, it speaks hormone chaos. That is the framework, that is the model. And that is why women deserve better than isolated answers. Because the dark patch on her face, the pain in her pelvis, the fatigue, the inflammation, the hormone sensitivity, may not be separate problems. They may be different chapters of the same biological book. And once you understand the book, you stop treating women like a collection of disconnected symptoms.

You start seeing the system. And that is where real understanding begins.